Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Type I Diabetes I: Introduction

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Type I Diabetes III: Clinical Manifestations

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Diagnosis and empirical treatment for community-acquired pneumonia in special situations: immunocompromised HIV negative and elderly patients].

Medicine·2020

Same author

[Effect of gastric bypass on the cardiovascular risk and quality of life in morbid obese patients].

Nutricion hospitalaria·2014

Same author

[Effectiveness of lifestyle intervention program in persons with obesity treated in a day hospital].

Revista de calidad asistencial : organo de la Sociedad Espanola de Calidad Asistencial·2013

Same author

[Analysis of the relevance and feasibility of quality indicators in nutrition support].

Nutricion hospitalaria·2012

Same author

[Efficacy, cost-effectiveness, and effects on quality of life of nutritional supplementation].

Nutricion hospitalaria·2011

Same author

[Influence of temperature on food intake in hospitalized patients].

Nutricion hospitalaria·2008

Search research articles

Related Experiment Video

Updated: Jul 28, 2026

Electrochemiluminescence Assays for Human Islet Autoantibodies

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

[Economic costs associated to type 1 diabetes].

M J Ballesta García¹, F Carral San Laureano, G Olveira Fuster

¹Distrito de Salud de Atención Primaria Bahía de Cádiz-La Janda, Cádiz.

Revista Clinica Espanola

|December 6, 2005

Summary

The economic burden of type 1 diabetes is significant, with direct costs exceeding indirect costs. Hospitalizations, pensioner status, and diabetes complications independently increase overall healthcare expenses.

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

Related Experiment Videos

Last Updated: Jul 28, 2026

Electrochemiluminescence Assays for Human Islet Autoantibodies

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

Area of Science:

Endocrinology
Health Economics
Public Health

Context:

Type 1 diabetes represents a significant global health challenge.
Accurate assessment of healthcare resource utilization and economic costs is crucial for effective management and policy-making.
Understanding the cost drivers associated with type 1 diabetes is essential for resource allocation and intervention strategies.

Purpose:

To determine the health resource utilization and economic cost associated with type 1 diabetes in a patient cohort.
To identify factors influencing the total economic cost of type 1 diabetes.

Summary:

A cross-sectional study analyzed 71 type 1 diabetes patients to assess annual direct and indirect costs.
The total average cost was €3,311 per patient per year, with direct costs (€2,104) higher than indirect costs (€1,250).
Regression analysis revealed that hospitalizations, pensioner status, and micro/macrovascular complications were independently associated with increased total costs.

Impact:

The study highlights the substantial economic impact of type 1 diabetes.
Findings underscore the importance of managing complications and hospitalizations to mitigate healthcare costs.
Results provide valuable data for healthcare providers, policymakers, and patient advocacy groups involved in diabetes care.